September's hottest authoritative guide TOP list is coming! The seven-day clinical diagnosis and treatment knowledge of National Day is "burning"!

Is it a headache to work for seven days in a row after National Day? Check out this list of guides and touch the "professional" fish!

We've compiled the top five most popular guides for September by department! Let's take a look at which clinical guidelines will make you shine too!

Tell you quietly: Click "Click here" of the guide list of each department to jump to the guide list area link to see more content!

1.
Cardiovascular (click here to view the complete cardiovascular guide TOP list)

5th place:

Chinese expert consensus on endovascular treatment of symptomatic intracranial atherosclerotic stenosis 2022

Introduction: This consensus updates part of the "Chinese Expert Consensus on the Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis 2018", combined with the latest research results and expert opinions, and provides recommendations for clinical precision treatment and stroke secondary prevention of ICAS patients
.
  

4th place:

Expert consensus on common experimental cardiovascular disease models in large and mice

Introduction: The prevalence of cardiovascular disease in China is in a continuous rising stage, and the 2020 China Cardiovascular Health and Disease Report estimates that the number of cardiovascular diseases is 330 million, of which stroke, coronary heart disease (coronary heart disease), heart failure are large, and hypertension, atrial fibrillation, atherosclerosis, cardiomyopathy are not only cardiovascular diseases, but also the main risk factors
for cardiovascular complications such as ischemic and hemorrhagic stroke, coronary heart disease and various heart failures.

3rd place:

Chinese The 2022 USPSTF Recommendation Statement: Vitamins, Minerals, and Multivitamin Supplements Prevent Cardiovascular Disease and Cancer

Summary: This article is an update of the 2014 version of the Statement of Recommendations, and the USPSTF does not recommend the use of β carotene or vitamin E supplements to prevent cardiovascular disease or cancer
.
Current evidence is insufficient to assess the balance
of benefits and harms of using terminal vitamin supplements for preventing cardiovascular disease or cancer.

2nd place:

Expert consensus on the clinical decision-making path of the "new quadruple" drug treatment for chronic heart failure

Introduction: This consensus proposes a concise and clear clinical decision-making path for the drug treatment of chronic heart failure, focusing on the initiation sequence, initiation timing, dosage and adjustment principles and clinical precautions of the "new quadruple" drugs, emphasizing the whole process and long-term management of patients with chronic heart failure in and out of the hospital, so as to promote the majority of clinicians to more standardize the application of drugs to improve the prognosis of heart failure, in order to reduce the hospitalization rate and mortality rate of patients with chronic heart failure in China and reduce the socioeconomic burden
caused by heart failure.

1st place:

Chinese 2022 AHA Scientific Statement: Cardiopulmonary consequences of vaping in adolescents

Introduction: The goal of this scientific statement is to provide important background information on the cardiorespiratory consequences of vaping in adolescents to guide treatment and prevention strategies and future research directions
.

2.
Respiratory Department (click here to view the TOP list of the complete respiratory guide)

5th place:

Interpretation of the International Consensus on Severe Lung Cancer (First Edition).

Introduction: Based on the diagnosis and treatment of severe lung cancer from a global perspective, the Consensus has two limitations for Chinese patients: first, the research population recommended by the Consensus may lack the representativeness and adaptability of Chinese patients; Second, compared with European and American countries, China has the advantages of traditional Chinese medicine and integrated traditional Chinese and Western medicine, but it is not mentioned
.
Therefore, this paper interprets the Consensus in order to provide reference
for the diagnosis and treatment of patients with severe lung cancer in China.

4th place:

Technical Guidelines for Influenza Vaccination in China (2022-2023)

Introduction: Recently, the Chinese Center for Disease Control and Prevention issued the Technical Guidelines for Influenza Vaccination in China (2022-2023), which has been updated and revised
on the basis of the 2021 version of the guidelines.

3th place:

Guidelines for the clinical application of proprietary Chinese medicines in the treatment of chronic obstructive pulmonary disease (2021)

Chronic obstructive pulmonary disease (COPD) is a common, preventable and treatable chronic airway disease characterized by persistent respiratory symptoms and airflow restriction, often caused
by significant exposure to toxic particles or gases and destruction of airway and alveolar structures 。 Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and comorbidities can have a significant impact
on the severity of the patient's overall disease.

2th place:

Chinese 2022 AHA Scientific Statement: Cardiopulmonary consequences of vaping in adolescents

Introduction: The goal of this scientific statement is to provide important background information on the cardiorespiratory consequences of vaping in adolescents to guide treatment and prevention strategies and future research directions
.

1th place:

2022 Global Asthma Management and Prevention Strategy (GINA) update

Summary: On World Asthma Day 2022 (4 May), the 2022 edition of the Global Strategy for Asthma Management and Prevention (GINA 2022) was released, incorporating new scientific evidence
on asthma.
The prevalence of asthma in China is increasing year by year, and the overall level of asthma control in China is not ideal.

This article mainly interprets the key points of the update of GINA 2022, discusses the management of asthma during the COVID-19 epidemic, and puts forward the significance
for the diagnosis and treatment of asthma in China.

3.
Oncology (click here to view the TOP list of the complete oncology guide)

5th place:

Interpretation of "Chinese Guidelines for Integrated Diagnosis and Treatment of Oncology (CACA)-Guidelines for the Diagnosis and Treatment of Thyroid Cancer"

Introduction: Thyroid cancer has become the fastest growing malignant tumor, ranking among the
top ten malignant tumors.
How to prevent, screen, diagnose, standardize treatment, rehabilitation and follow-up thyroid cancer will be an important guarantee for improving the survival rate of thyroid cancer and improving the quality of life in China, and it is also an important responsibility
for experts in the thyroid field.
In order to better promote the clinical management of thyroid cancer in China, the Thyroid Cancer Professional Committee of the Chinese Anti-Cancer Association organized relevant experts to compile this guide
based on the latest literature and Chinese experience.
This guide covers the disease management of different pathological types of thyroid cancer, including papillary thyroid carcinoma, follicular carcinoma, medullary carcinoma, and undifferentiated carcinoma, aiming to provide guidance and reference
for the standardized diagnosis and treatment of thyroid cancer in China.

4th place:

Chinese Guidelines for Integrated Diagnosis and Treatment of Oncology (CACA) - Liver Cancer Section

Introduction: Advocated by Academician Fan Daiming, chairman of the Chinese Anti-Cancer Association, the Chinese Anti-Cancer Association organized experts in the field of oncology medicine to jointly participate in the compilation of the "Chinese Guidelines for Integrated Diagnosis and Treatment of Oncology (CACA)", and the Liver Cancer Professional Committee of the Chinese Anti-Cancer Association organized industry experts to complete the compilation of this guide in accordance with the structure of "prevention-screening-diagnosis-treatment-health" of the National Health Commission Multidisciplinary integrated treatment methods such as screening, imaging examination, pathological evaluation, as well as surgical treatment, interventional therapy, systemic drug treatment, radiotherapy and traditional Chinese medicine treatment, take into account the whole process of rehabilitation management
.
The full text implements the "concept of integrated medicine", takes "basing on China's national conditions and embodying Chinese characteristics" as the guiding ideology, pays attention to the inclusion of China's clinical research results and experience, and formulates clinical diagnosis and treatment guidelines suitable for Chinese groups, closely combined with China's specific national conditions and clinical practice, and in line with the characteristics of Chinese liver cancer, which will play an important role
in further improving the diagnosis and treatment level of liver cancer in China.

3th place:

Guidelines for the diagnosis and treatment of neuroendocrine tumors of the Chinese Anti-Cancer Association (2022 edition)

Introduction: Neuroendocrine neoplasm (NEN) is a rare tumor originating from peptidergic neurons and neuroendocrine cells, with neuroendocrine differentiation and expressing neuroendocrine markers, which can occur throughout the body, with lung and gastrointestinal pancreatic NEN (gastroenteropancreatic neuroendocrine neoplasm, GEP-NEN) being the
。 Research data at home and abroad suggest that the incidence of NEN is increasing
.
The results of epidemiological surveys in the United States show that the incidence of NEN is more significant
than other types of tumors.
On the basis of the existing evidence-based medical evidence, combined with the existing domestic and foreign guidelines and consensus, the Neuroendocrine Oncology Committee of the Chinese Anti-Cancer Association formulated the first edition of the guidelines for the diagnosis and treatment of neuroendocrine tumors of the Chinese Anti-Cancer Association to provide reference
for clinical workers.

2th place:

Interpretation of the Chinese Guidelines for the Evidence-Based Use of High-dose Methotrexate

Introduction: The Chinese Guidelines for the Evidence-Based Use of High-dose Methotrexate were published in the British Journal of Clinical Pharmacology in February 2022, which strictly follow the latest definitions of clinical practice guidelines and the methodological norms developed by WHO guidelines, and use the Evaluation, Development and Evaluation (GRADE) tool to evaluate the quality of evidence and grade the strength of recommendations.
Finally, 28 recommendations covering the whole clinical course of high-dose methotrexate were formed, including pre-medication assessment (liver and kidney function, pleural effusion and ascites, concomitant medication, genetic testing), pretreatment and routine dosing regimen (hydration alkalinization pretreatment, urine alkalinization, routine dosing regimen), therapeutic drug monitoring (necessity, method, timing, target concentration), leucovorin rescue (rescue timing, rescue protocol, rescue dose optimization), adverse event management (liver and kidney function monitoring, supportive care, blood purification treatment), etc
.
This article aims to summarize and interpret the recommendations of the guidelines in Chinese version, so as to promote the better promotion and implementation of the guidelines in China, and provide comprehensive technical support and use suggestions
for the individualized administration of high-dose methotrexate.

1th place:

Guidelines for Screening Chinese Liver Cancer (2022, Beijing)

Introduction: The Chinese population of liver cancer has a low survival rate and high mortality, how to effectively reduce the burden of liver cancer is still a major problem to be solved in the field of public health and chronic disease prevention and control in China, and the optimization of liver cancer population screening strategy is an important starting point and direction
worthy of continuous exploration 。 Entrusted by the National Health Commission Bureau for Disease Control and Prevention, initiated by the National Cancer Center, the Chinese group of liver cancer screening guidelines are initiated by the National Cancer Center, and multidisciplinary experts are combined to formulate principles and methods according to the guidelines recommended by the World Health Organization, integrate new research evidence in the field of liver cancer population screening, take into account China's national conditions and practical experience, and present evidence-based recommendations for the screening population, screening technology, monitoring program, etc.
in the liver cancer screening process, in order to provide reference
for the standardization of liver cancer screening practices in Chinese groups.

4.
Hematology (click here to view the TOP list of the complete hematology guide)

5th place:

Guidelines for the diagnosis and treatment of hemophilia A (2022 edition)

Introduction: hemophilia A (HA) is an inherited bleeding disorder that is inherited in an X-linked recessive manner
.
Clinically, it is mainly manifested as abnormalities
in the quality or quantity of coagulation factor VIII (FVIII.
).
Clinical manifestations are characterized by spontaneous or difficult to stop bleeding after spontaneous or minor trauma in joints, muscles, internal organs, and deep tissues, often beginning in childhood, and repeated joint bleeding can lead to gradual joint mobility impairment and disability
.
In the male population, the incidence of HA is about 1 in 5,000, while in women patients with hemophilia is extremely rare
.
The prevalence of hemophilia in China is 2.
73/100,000 population, of which HA accounts for 80%~85%.

4th place:

Chinese expert consensus on fertility protection in girls with hematopoietic stem cell transplantation

Brief introduction:

Hematopoietic stem cell transplantation (HSCT) is a treatment method that removes tumor cells and abnormal cloned cells from the body through ultra-large doses of radiotherapy or chemotherapy, while destroying the recipient's immune system, reducing or eliminating the recipient's rejection of the donor's hematopoietic stem cells, and then transfusing hematopoietic stem cells of itself (autologous) or others (allogeneic) to rebuild normal hematopoietic and immune function
。

3th place:

2021 TIF guidelines: management of transfusion-dependent thalassemia

Brief introduction:

The International Federation of Thalassaemia (TIF) has published guidelines for the management of transfusion-dependent thalassaemia 2021, β-thalassaemia, especially for transfusion-dependent (TDT) patients, who require lifelong care, preferably managed by specialized centers and multidisciplinary teams
.
Despite significant advances in the diagnosis and treatment of TDT over the past few decades, its management remains challenging
.
This article provides guidance on
the management of transfusion-dependent thalassemia.

2th place:

2022 NHS clinical guidelines: Iron deficiency anaemia in adults Oral and intravenous iron therapy

Brief introduction:

This guideline focuses on the diagnosis and treatment
of iron deficiency anaemia (IDA) in adult patients (16 years of age and older) in acute and primary care settings.
Treatment of IDA includes oral and intravenous (IV) iron replacement therapy
.

1th place:

2022 EHA consensus recommendation: antifungal prophylaxis of novel targeted therapies for acute myeloid leukemia in adults

Summary: In addition to improving overall survival, treatment guidelines strongly recommend induction remission chemotherapy
in patients with acute myeloid leukemia.
Many novel targeted drugs are metabolized by cytochrome P450, but the potential drug-drug interaction (DDI) and the resulting risk-benefit ratio have not been evaluated in clinical trials, leading to uncertainty
in clinical management.
Therefore, the European Society of Hematology commissioned expert pharmacology and methodology in the fields of infectious diseases, hematology, oncology and clinical to develop the latest recommendations on the preventive action of antifungals, as well as the pharmacokinetic DDI management
of triazole antifungals.
A systematic literature review was conducted based on the Cochrane methodology, using recommendation ratings to develop recommendation assessments, develop and evaluate the evidence for decision-making
frameworks.

V.
Neurology (Click here to view the TOP list of the full neurology guide)

5th place:

2022 AA Recommendation: Appropriate Application of Blood Biomarkers for Alzheimer's Disease

Summary: In July 2022, the Alzheimer's Association (AA) published recommendations
for the appropriate use of blood biomarkers for Alzheimer's disease.
Blood biomarkers promise to revolutionize the diagnosis and prognostic testing of Alzheimer's disease, and this article discusses in detail the further research that needs to be done before blood biomarkers can be widely used, and suggests appropriate applications
.

4th place:

2022 NHS clinical guidelines: Coronary heart disease and stroke, primary and secondary prevention guidelines (cholesterol)

Summary: High-risk patients (expected cardiovascular event rate of 20% or more within 10 years) should receive statin therapy without additional risk assessment
for all patients aged 40 years with diabetes and those aged < 40 years of diabetes > 20 years or with target organ damage.
≥
。 Aspirin is not a regular indication for diabetics because they are not aware of atherosclerosis
.

Treatment of patients with chronic kidney disease (CKD 3-5) without additional risk assessment
.
There is no evidence of cardiovascular benefit
from starting statins in patients already on dialysis.

3th place:

2020 TSS guidelines: Blood pressure management in the acute phase of ischemic stroke

Introduction: In July 2022, the Alzheimer's Association (AA) published recommendations
for the appropriate use of blood biomarkers for Alzheimer's disease.
Blood biomarkers promise to revolutionize the diagnosis and prognostic testing of Alzheimer's disease, and this article discusses in detail the further research that needs to be done before blood biomarkers can be widely used, and suggests appropriate applications

2th place:

2022 ESO guidelines: Long-term secondary preventive pharmacological interventions after ischemic stroke or transient ischemic attack

Introduction: Recurrent strokes affect 9% to 15% of people
within 1 year.
This European Stroke Organization (ESO) guideline provides evidence-based recommendations on medication management of blood pressure (BP), diabetes, lipid levels, and antiplatelet therapy to prevent recurrent stroke and other important outcomes (TIAs)
in patients with ischaemic stroke or transient ischaemic attack.

1th place:

Chinese expert consensus on endovascular treatment of symptomatic intracranial atherosclerotic stenosis 2022

Introduction: intracranial atherosclerotic stenosis (ICAS), also known as intracranial atherosclerotic disease (ICAD), is a common cause of ischemic stroke, and its incidence has obvious racial differences, which tends to occur in Asian, black and Hispanic populations.
and the resulting global stroke burden is increasing ^[1].

This consensus updates part of the "Chinese Expert Consensus on the Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis 2018", combined with the latest research results and expert opinions, and provides recommendations for clinical precision
treatment and stroke secondary prevention of ICAS patients.

6.
Department of Psychiatry and Psychology (click here to view the TOP list of the complete psychiatric and psychological guide)

5th place:

2022 WFSBP Guide: Treatment of Anxiety, OCD, and Post-Traumatic Stress Disorder (3rd Edition) - Part II: OCD and PTSD

Introduction: In July 2022, the World Federation of Biological Psychiatric Societies (WFSBP) released the third edition of the guidelines for the treatment of anxiety, obsessive-compulsive disorder and post-traumatic stress disorder, and this article is part 2 of the guidelines, which mainly deals with the treatment
of anxiety disorders.
The primary objective is to provide effective treatment guidance for
obsessive-compulsive disorder and post-traumatic stress disorder.

4th place:

Expert recommendations for the clinical application of trazodone hydrochloride extended-release agents

Introduction: Trazodone hydrochloride extended-release agent, as a multi-receptor binding drug, can exert different pharmacological effects and improve a variety of mental disorders
in different doses.
In order to further standardize the clinical application of trazodone hydrochloride extended-release agent, this expert writing group integrated clinical trials, clinical practice guidelines, prescription guidelines and clinical medication experience at home and abroad, and wrote this clinical application expert recommendation
.
This article mentions that trazodone hydrochloride extended-release agent is clinically suitable for depression, insomnia caused by various reasons, and is also used in generalized anxiety disorder, sexual dysfunction, post-traumatic stress disorder, substance dependence and withdrawal and obsessive-compulsive disorder, and explains the dosage and interaction of drugs, as well as precautions for the use of special populations, in order to provide clinicians with scientific and comprehensive medication guidance
.

3th place:

2022 WFSBP Guideline: Treatment of Anxiety, OCD, and Post-Traumatic Stress Disorder (3rd Edition) – Part I: Anxiety Disorders

Introduction: In July 2022, the World Federation of Biological Psychiatric Societies (WFSBP) released the 3rd edition of its guidelines for the treatment of anxiety, obsessive-compulsive disorder and post-traumatic stress disorder, which is part 1 of the guidelines and mainly deals with the treatment
of anxiety disorders.
The main objective is to provide effective treatment recommendations
for anxiety disorders.

2th place:

2022 Guide for Mental Health Professionals: Remote Counseling for Intimate Partner Survivors

Introduction: Providing psychosocial interventions through telehealth is one way to
reduce intimate partner violence (IPV).
However, given the safety risks to survivors and the need for emergency support, remote counseling
for IPV survivors needs to be handled sensitively.
This article provides strategies to address such issues while providing interventions
for IPV survivors using telehealth in clinical settings.
Strategies for screening, assessment, planning psychosocial interventions, and meeting termination are also summarized
along with supportive guidelines.

1th place:

Expert consensus on the clinical application of psychiatric therapeutic drug monitoring in China (2022 edition)

Introduction: Psychiatry is one of the earliest disciplines to carry out therapeutic drug monitoring (TDM) in China, TDM has played an important role in individualized treatment, but there are still some problems to be solved
in clinical application.
In view of the problems in the clinical application of psychiatric TDM, the Chinese Pharmacological Society Therapeutic Drug Monitoring Research Committee took the lead and jointly formulated the "Expert Consensus on the Clinical Application of Psychiatric Therapeutic Drug Monitoring in China (2022 Edition)"
jointly formulated by three professional committees.
This consensus involves the clinical implementation, result interpretation, clinical decision-making and special populations of psychiatric TDM, and plays a normative and guiding role
in the clinical application of psychiatric TDM.

7.
Department of Dermatology and Venereology (click here to view the TOP list of complete dermatology guidelines)

5th place:

2022 Practice Guide: Management of Patients with Hidradenitis suppurativa (Updated)

Introduction: Hidradenitis suppurativa is a chronic inflammatory skin disease, and this article mainly provides guidance for the management of hidradenitis suppurativa and its comorbidities to improve the management and treatment
of such patients.

4th place:

2022 S2K Guide: Rosacea

Introduction: This updated and upgraded S2K guideline deals with the diagnosis and treatment of rosacea, a common chronic inflammatory skin condition that primarily affects the face
.

3th place:

2022 European guidelines: Atopic eczema (dermatitis) – Part II: Treatment recommendations for patients with non-systemic therapy and specific AEs

Introduction: The purpose of the European Guidelines for Atopic Eczema is to provide guidance on the management of all atopic eczema (dermatitis), Part II of the guidelines, which deals mainly with non-systemic treatment and treatment recommendations
for patients with specific AEs.

2th place:

2021 JDA clinical practice guidelines: management of atopic dermatitis

Introduction: This article is the English version
of Japan's 2021 guidelines for the management of atopic dermatitis.
Atopic dermatitis (AD) is a disease characterized by recurrent eczema, and this article provides guidance on the diagnosis and treatment of AD, including instructions for the use of 3 new drugs, including dupilumab, delgocitinib, and baricitinib
.

1th place:

2022 European guidelines: Atopic eczema (dermatitis) – Part I: Systemic therapy

Introduction: The purpose of the European Guidelines for Atopic Eczema is to provide guidance on the management of all atopic eczema (dermatitis), Part I of this guideline deals primarily with the systematic treatment
of atopic eczema (dermatitis).

8.
Department of Rheumatology and Immunology (Click here to view the TOP list of the complete rheumatology and immunology guidelines)

5th place:

2022 Living Guide for the Management of Idiopathic Arthritis in Adolescents in Australia

Introduction: The treatment of juvenile idiopathic arthritis (JIA) is constantly evolving
.
New management approaches, including "targeted treatment") and the rapid expansion of available disease-modifying antirheumatic drugs (DMARDs), have improved outcomes
in children and young adults with JIA.
The rate of new evidence on treatments is increasing, which means that recommendations based on current evidence may soon become obsolete
as new research is published.
The live evidence approach helps to update recommendations
quickly.
By regularly incorporating the latest evidence, these methods ensure that the prevalence of each recommendation remains high
.

4th place:

2022 BSACI guidelines: Diagnosis and management of pollen-food syndrome

Summary: In August 2022, the British Society of Allergy and Clinical Immunology (BSACI) published guidelines
for the diagnosis and management of pollen-fed food syndrome.
Pollen Food Syndrome (PFS) is a highly prevalent food allergy in which people experience allergy symptoms when using raw plant foods because pollen allergy in these foods is homologous
to unstable proteins.
This article provides guidance on
the diagnosis and management of pollen food syndrome.

3th place:

Interpretation of the 2021 ACR Guidelines for the Treatment of Juvenile Idiopathic Arthritis

Introduction: In March 2022, the American College of Rheumatology (ACR) issued guidelines for the treatment of juvenile idiopathic arthritis (JIA) (2021), focusing on the treatment pathway for oligoarticular, temporomandibular arthritis, and systemic (with or without macrophage activation syndrome), and also gave recommendations
for inactive sJIA reduction.
The main point of explanation is that glucocorticoids should not be used for a long time in children, and should be carried out
at the lowest effective dose for the shortest possible time of use.
When considering treatment options, it is important
for doctors to make decisions together with families and patients.
During the active phase, start biosynthetic disease-modifying antirheumatic agents (bDMARDs) or combination with conventionally synthesized disease-modifying antirheumatic drugs (csDMARDs) as early as possible
.
In non-systemic JIA, bDMARD is not preferred, TNFi is the most commonly used, and csDMARD is preferred
by methotrexate.
IL-1 or IL-6 inhibitors are preferred for systemic JIA, and if the response is poor, atacept and TNFi can be replaced by
atacept.
It should be noted that all recommendations were rated as low or very low quality
.

2th place:

Interpretation and comparison of the latest gout diagnosis and treatment guidelines at home and abroad

Introduction: Gout is a crystal-related arthropathy caused by monosodium urate deposition, which is directly related
to hyperuricemia due to disorders of purine metabolism and/or decreased uric acid excretion.
Its incidence is increasing year by year around the world and has become an important disease
that threatens people's health and quality of life.
Therefore, many countries have successively issued guidelines for the diagnosis and treatment of
gout.
By interpreting and comparing the differences between the latest gout diagnosis and treatment guidelines at home and abroad, clinicians can learn the latest diagnosis and treatment concepts and treatment plans, and at the same time obtain more comprehensive clinical diagnosis and treatment guidance and evidence support
.

1th place:

2022 CRA guidelines: Treatment of rheumatoid arthritis with disease-modifying antirheumatic drugs

In July 2022, the Canadian Society of Rheumatology (CRA) published guidelines
on the use of disease-modifying antirheumatics for the treatment of rheumatoid arthritis.
It mainly provides guidance and suggestions for the use of bDMARDs and
tsDMARDs in the treatment of RA.

9.
Department of Rare Diseases (click here to view the full TOP list of rare disease guidelines)

5th place:

Guidelines for the diagnosis and treatment of hemophilia A (2022 edition)

Introduction: hemophilia A (HA) is an inherited bleeding disorder that is inherited in an X-linked recessive manner
.
Clinically, it is mainly manifested as abnormalities
in the quality or quantity of coagulation factor VIII (FVIII.
).
Clinical manifestations are characterized by spontaneous or difficult to stop bleeding after spontaneous or minor trauma in joints, muscles, internal organs, and deep tissues, often beginning in childhood, and repeated joint bleeding can lead to gradual joint mobility impairment and disability
.
In the male population, the incidence of HA is about 1 in 5,000, while in women patients with hemophilia is extremely rare
.
The prevalence of hemophilia in China is 2.
73/100,000 population, of which HA accounts for 80%~85%.

4th place:

2022 Asian Clinical Recommendations: Diagnosis and monitoring of patients with transthyretin amyloidosis cardiomyopathy

Introduction: Transthyretin amyloidosis cardiomyopathy (ATTR-CM) presents a debilitating and fatal disease
with diverse clinical manifestations.
This article provides practical guidance for the diagnosis and monitoring of ATTR-CM in Asia
.

3th place:

Diagnostic criteria for autoimmune encephalitis and their clinical guidance

Introduction: Autoimmune encephalitis is a newly discovered autoimmune disease of the central nervous system, and the corresponding autoantibodies are helpful in diagnosis
.
However, over-reliance on autoantibody testing often leads to diagnostic delays and is detrimental to treatment
.
To address this problem, it is imperative to develop clinical diagnostic criteria based on relatively specific clinical findings and laboratory tests
for the diagnosis of the disease.
In this paper, the newly formulated clinical diagnostic criteria for autoimmune encephalitis are introduced and their guiding value
for clinical practice is discussed.

2th place:

2022 International consensus recommendation: Evaluation and management of patients with CDKL5 deficiency

CDKL5 deficiency (CDD) is a rare neurodevelopmental disorder caused by mutations in the CDKL5 gene located on the X chromosome
.
This article provides consensus guidance for
the evaluation and management of patients with CDKL5 deficiency.

1th place:

2022 NICE Guidelines: Multiple Sclerosis in Adults

Summary: In June 2022, the UK's National Institute for Health and Care Excellence (NICE) published guidelines
for the management of multiple sclerosis in adults.
Guidelines cover the diagnosis and treatment
of multiple sclerosis in adults aged 18 years and older.
The aim is to improve the quality of life of patients with multiple sclerosis by promoting timely and effective symptom management and treatment of
disease recurrence.

That's it for September! If you want to see more department guidelines, you can enter the clinical guidelines section → the official website of Mace Medicine, or download the Mace Medical APP to search for more guidelines for your heart; If you have friends who want to see the list of other departments, please let us know in the comment message!

There is also good news to tell you that the membership rights of Mace Medical Guide are officially open! For only 19 yuan in the first month, you can enjoy the 20,000+ high-quality clinical guidelines of the Mace Medical Guide Library for free points! More member rights are still in active preparation, don't miss it! See ↓ below for details

Click here to access the purchase link!